BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Oct 26, 2022 2:22pm

48 Views

Post# 35050791

BIOV HOLY SHYTE SMUCKERS 1.4 MILLION WHO? WHERE? WHEN? HOW?

NOW????

C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com

14:21:30 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BIOV - C	1.5	0.23	·	0.24	33.5	0.24	+0.015	6.7	1,421.0	293	270	0.23 0.24 0.195	0.395 0.085	14:02:56	Oct 14	15 min RT 2¢
CSE - C	1.5	0.23	·	0.24	33.5	0.24	+0.015	6.7	517.8	106	129	0.23 0.24 0.195	0.395 0.085	14:02:39		15 min
NEO ATS - U						0.24	+0.015	6.7	805.0	168	115	0.22 0.24 0.195		14:02:56		15 min
Omega - O						0.22	-0.005	-2.2	82.0	17	19	0.22 0.23 0.20		13:59:23		15 min
CX2 - H						0.20	-0.025	-11.1	16.0	3	6	0.21 0.21 0.20		13:45:19		15 min
TriAct - M						0.225			0.1		1					15 min